Notify me when Eric Easom files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | Common Stock, par value $0.00001 per share | 7.9% | $2,946,245 | +$447,311 | 2,232,004 | +18% | Eric Easom | 31 Dec 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|